Shaanxi Kanghui Pharmaceutical Co., Ltd.SSE: 603139

(603139)"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Supplementing the Estimated Guarantee Amount for Controlled Subsidiaries

· Issued by Shaanxi Kanghui Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603139 · · 6 pages · Chinese

Summary by 6ix AI

Shaanxi Kanghui Pharmaceutical Co., Ltd. announced a supplement to the estimated guarantee amount for its controlled subsidiaries, detailing the new financial support planned for these entities. The company plans to increase the guarantee amount to support financing needs, with specific details on the subsidiaries involved and the decision-making process outlined. The board of directors has approved this increase, emphasizing that it aligns with the company's strategic interests and does not harm shareholder rights.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603139shaanxi-kanghui-pharmaceutical-co-ltdannouncement-on-supplementing-the-estimated-guarantee-amount-for-controlled-subsidiaries

Release

Announcement on Supplementing the Estimated Guarantee Amount for Controlled Subsidiaries

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Shaanxi Kanghui Pharmaceutical

All Shaanxi Kanghui Pharmaceutical news releases